
    
      The aim of this study is to investigate the efficacy and safety of lopinavir /ritonavir and
      recombinant Interferon beta-1b combination given with optimal supportive care compared to
      placebo with optimal supportive care for patients with laboratory-confirmed MERS-CoV
      infection requiring hospital admission.
    
  